{"id":1883,"date":"2002-11-01T12:07:00","date_gmt":"2002-11-01T11:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2002\/leserbrief-nochmals-herzinsuffizienz-und-betarezeptoren-blocker"},"modified":"2002-11-01T12:07:00","modified_gmt":"2002-11-01T11:07:00","slug":"leserbrief-nochmals-herzinsuffizienz-und-betarezeptoren-blocker","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2002\/leserbrief-nochmals-herzinsuffizienz-und-betarezeptoren-blocker","title":{"rendered":"Leserbrief: Nochmals: Herzinsuffizienz und Betarezeptoren-Blocker"},"content":{"rendered":"<p>Dr. A.T. aus Ravensburg schreibt: >> In Ihrer Leserbrief-Antwort (AMB 2002, 36, 72) zitieren Sie L.W. Stevenson (N. Engl. J. Med. 2002, 346, 1346): \u201dNur solche (Beta-Blocker) sind angezeigt, die selektiv Beta1-Rezeptoren blockieren, wie Metoprolol und Bisoprolol, und bedingt auch solche, die Beta1&#8211; und Beta2-Rezeptoren blockieren, wie Carvedilol.\u201d In der Originalarbeit von Stevenson kann ich [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. A.T. aus Ravensburg schreibt: >> In Ihrer Leserbrief-Antwort (AMB 2002, 36, 72) zitieren Sie L.W. Stevenson (N. Engl. J. Med. 2002, 346, 1346): \u201dNur solche (Beta-Blocker) sind angezeigt, die selektiv Beta1-Rezeptoren blockieren, wie Metoprolol und Bisoprolol, und bedingt auch solche, die Beta1&#8211; und Beta2-Rezeptoren blockieren, wie Carvedilol.\u201d In der Originalarbeit von Stevenson kann ich [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[129,128,131,1635,2527,1639,180,2276,633],"class_list":["post-1883","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-bisoprolol","tag-capricorn-studie","tag-carvedilol","tag-herzinsuffizienz","tag-merit-hf-studie","tag-metoprolol"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1883"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1883\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}